Earnings season is picking up and results are driving big share price pop and drops in companies that are beating or missing on forecasts.
In the following slideshow, I address the key reasons behind each of these companies surge or purge.
Leaked: This coming blockbuster will make these 4 stocks jealous
The best biotech investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not just how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool's new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.